FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1594832069> ?p ?o ?g. }

• W1594832069 endingPage "500" @default.
• W1594832069 startingPage "494" @default.
• W1594832069 abstract "Inhalers combining long acting beta2-adrenoceptor agonists (LABA) and corticosteroids (ICS) are indicated at Step 3 of current asthma guidelines. We evaluated the relative effects of LABA + ICS combination vs ICS alone on pulmonary function, bronchoprotection, acute salbutamol recovery following methacholine bronchial challenge, and surrogate inflammatory markers in patients with moderate persistent asthma.Twenty-nine patients with mean FEV1 (+/- SEM) of 78 +/- 3% predicted completed a randomized, double-blind, double-dummy, cross-over study. Patients received either 4 weeks of budesonide 400 microg + formoterol 12 microg (BUD + FM) combination twice daily followed by 1 week of BUD 400 microg alone twice daily, or 4 weeks of fluticasone propionate 250 microg + salmeterol 50 microg (FP + SM) combination twice daily followed by 1 week of FP 250 microg alone twice daily. Measurements were made at baseline and following each randomized treatment.FEV1 increase from pretreatment baseline as mean (+/- SEM) % predicted was significantly higher (P < 0.05) for BUD + FM (8 +/- 1%) vs BUD (2 +/- 1%), and for FP + SM (8 +/- 1%) vs FP (2 +/- 1%). The fall in FEV1 following methacholine challenge as percentage change from prechallenge baseline FEV1 was not significantly different in all four groups; BUD + FM (22 +/- 1%), BUD (24 +/- 1%), FP + SM (23 +/- 1%) and FP (23 +/- 1%). Salbutamol recovery over 30 min following methacholine challenge as area under curve (AUC %.min) was significantly blunted (P < 0.05) with BUD + FM (486.7 +/- 35.5) vs BUD (281.1 +/- 52.8), and with FP + SM (553.1 +/- 34.1) vs FP (368.3 +/- 46.7). There were no significant differences between respective combination inhalers or between respective ICS alone. Decreases in exhaled nitric oxide (NO) and serum eosinophilic cationic protein (ECP) from baseline were not significantly different between treatments.Combination inhalers improve pulmonary function without potentiating anti-inflammatory effects on exhaled NO and serum ECP as compared with ICS alone, but delay acute salbutamol recovery after bronchoconstriction." @default.
• W1594832069 created "2016-06-24" @default.
• W1594832069 creator A5020266399 @default.
• W1594832069 creator A5020976927 @default.
• W1594832069 creator A5054519215 @default.
• W1594832069 creator A5057517490 @default.
• W1594832069 creator A5089023588 @default.
• W1594832069 date "2003-08-04" @default.
• W1594832069 modified "2023-10-14" @default.
• W1594832069 title "Comparison of combination inhalers <i>vs</i> inhaled corticosteroids alone in moderate persistent asthma" @default.
• W1594832069 cites W1497621792 @default.
• W1594832069 cites W1715349870 @default.
• W1594832069 cites W1966561808 @default.
• W1594832069 cites W1967847611 @default.
• W1594832069 cites W1975315932 @default.
• W1594832069 cites W1981638219 @default.
• W1594832069 cites W1981992864 @default.
• W1594832069 cites W1982060405 @default.
• W1594832069 cites W1995257163 @default.
• W1594832069 cites W2009463623 @default.
• W1594832069 cites W2010733043 @default.
• W1594832069 cites W2013037468 @default.
• W1594832069 cites W2022008229 @default.
• W1594832069 cites W2023335735 @default.
• W1594832069 cites W2027285152 @default.
• W1594832069 cites W2028377192 @default.
• W1594832069 cites W2028513253 @default.
• W1594832069 cites W2033855435 @default.
• W1594832069 cites W2035724582 @default.
• W1594832069 cites W2037007193 @default.
• W1594832069 cites W2037885100 @default.
• W1594832069 cites W2042562343 @default.
• W1594832069 cites W2045660738 @default.
• W1594832069 cites W2049853440 @default.
• W1594832069 cites W2063045365 @default.
• W1594832069 cites W2068151155 @default.
• W1594832069 cites W2070079663 @default.
• W1594832069 cites W2074567872 @default.
• W1594832069 cites W2098894574 @default.
• W1594832069 cites W2109795756 @default.
• W1594832069 cites W2116614343 @default.
• W1594832069 cites W2117472799 @default.
• W1594832069 cites W2121540830 @default.
• W1594832069 cites W2121545123 @default.
• W1594832069 cites W2139297598 @default.
• W1594832069 cites W2144343902 @default.
• W1594832069 cites W2153952304 @default.
• W1594832069 cites W2331287401 @default.
• W1594832069 cites W2604596332 @default.
• W1594832069 cites W4236639597 @default.
• W1594832069 doi "https://doi.org/10.1046/j.1365-2125.2003.01887.x" @default.
• W1594832069 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1884386" @default.
• W1594832069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14651722" @default.
• W1594832069 hasPublicationYear "2003" @default.
• W1594832069 type Work @default.
• W1594832069 sameAs 1594832069 @default.
• W1594832069 citedByCount "52" @default.
• W1594832069 countsByYear W15948320692012 @default.
• W1594832069 countsByYear W15948320692013 @default.
• W1594832069 countsByYear W15948320692014 @default.
• W1594832069 countsByYear W15948320692015 @default.
• W1594832069 countsByYear W15948320692016 @default.
• W1594832069 countsByYear W15948320692018 @default.
• W1594832069 countsByYear W15948320692019 @default.
• W1594832069 countsByYear W15948320692020 @default.
• W1594832069 countsByYear W15948320692021 @default.
• W1594832069 crossrefType "journal-article" @default.
• W1594832069 hasAuthorship W1594832069A5020266399 @default.
• W1594832069 hasAuthorship W1594832069A5020976927 @default.
• W1594832069 hasAuthorship W1594832069A5054519215 @default.
• W1594832069 hasAuthorship W1594832069A5057517490 @default.
• W1594832069 hasAuthorship W1594832069A5089023588 @default.
• W1594832069 hasBestOaLocation W15948320691 @default.
• W1594832069 hasConcept C126322002 @default.
• W1594832069 hasConcept C168563851 @default.
• W1594832069 hasConcept C204243189 @default.
• W1594832069 hasConcept C2776042228 @default.
• W1594832069 hasConcept C2776136866 @default.
• W1594832069 hasConcept C2776178081 @default.
• W1594832069 hasConcept C2776719499 @default.
• W1594832069 hasConcept C2776804153 @default.
• W1594832069 hasConcept C2776954882 @default.
• W1594832069 hasConcept C2777394947 @default.
• W1594832069 hasConcept C2777714996 @default.
• W1594832069 hasConcept C2779028295 @default.
• W1594832069 hasConcept C2779871671 @default.
• W1594832069 hasConcept C2781260171 @default.
• W1594832069 hasConcept C42219234 @default.
• W1594832069 hasConcept C71924100 @default.
• W1594832069 hasConcept C75603125 @default.
• W1594832069 hasConcept C90924648 @default.
• W1594832069 hasConceptScore W1594832069C126322002 @default.
• W1594832069 hasConceptScore W1594832069C168563851 @default.
• W1594832069 hasConceptScore W1594832069C204243189 @default.
• W1594832069 hasConceptScore W1594832069C2776042228 @default.
• W1594832069 hasConceptScore W1594832069C2776136866 @default.
• W1594832069 hasConceptScore W1594832069C2776178081 @default.
• W1594832069 hasConceptScore W1594832069C2776719499 @default.

• next